New study tracks safety of ultomiris in pregnant women
NCT ID NCT06312644
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 75 pregnant women who have taken Ultomiris (ravulizumab) for conditions like PNH or aHUS. Researchers will track pregnancy outcomes and baby health up to one year after birth. The goal is to gather safety information, not to test a new treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Ultomiris (ravulizumab)
What this could lead to
If successful, this study could provide important safety data on using Ultomiris during pregnancy, helping doctors and patients make informed decisions.
What could go wrong
This is an observational study, not a controlled trial, so it cannot prove cause and effect. Results may be limited by the small number of participants (75) and lack of a comparison group.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREGNANCY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
RECRUITINGBoston, Massachusetts, 02210, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Research Site
NOT_YET_RECRUITINGMelbourne, Victoria, 3050, Australia
Contact
-
Research Site
RECRUITINGParis, 75475, France
Contact
-
Research Site
RECRUITINGEssen, Norte-Westfalia, D-45147, Germany
Contact
-
Research Site
RECRUITINGRome, 00168, Italy
Contact
-
Research Site
ACTIVE_NOT_RECRUITINGSeoul, South Korea
-
Research Site
ACTIVE_NOT_RECRUITINGLondon, SE5 9NU, United Kingdom